Research Letter  November 2, 2023 Changes in Employment in the US Health Care Workforce, 2016-2022 Thuy Nguyen, Christopher Whaley, Kosali I. Simon, et al JAMA. 2023;330(20):2018-2019. doi:10.1001/jama.2023.18932 The COVID-19 pandemic has caused a variety of disruptions to the health care workforce.1Data on select health care workforce sectors chronicle patterns in employment through 2021.1-3 Lack of national studies on the broad health care workf...

Research Implementation of a high sensitivity cardiac troponin I assay and risk of myocardial infarction or death at five years: observational analysis of a stepped wedge, cluster randomised controlled trial Kuan Ken Lee, Dimitrios Doudesis, Amy V Ferry, et al BMJ 2023; 383 doi: https://doi.org/10.1136/bmj-2023-075009 (Published 28 November 2023)Cite this as: BMJ 2023;383:e075009 Abstract Objective To evaluate the impact of implementing a high sensitiv...

Research Covid-19 vaccine effectiveness against post-covid-19 condition among 589 722 individuals in Sweden: population based cohort study Lisa Lundberg-Morris, Susannah Leach, Yiyi Xu, et al BMJ 2023; 383 doi: https://doi.org/10.1136/bmj-2023-076990 (Published 22 November 2023)Cite this as: BMJ 2023;383:e076990 Abstract Objective To investigate the effectiveness of primary covid-19 vaccination (first two doses and first booster dose within the recomme...

ORIGINAL ARTICLE Intravenous Levothyroxine for Unstable Brain-Dead Heart Donors Rajat Dhar, Gary F. Marklin, W. Dean Klinkenberg, et al N Engl J Med 2023; 389:2029-2038DOI: 10.1056/NEJMoa2305969 BACKGROUND Hemodynamic instability and myocardial dysfunction are major factors preventing the transplantation of hearts from organ donors after brain death. Intravenous levothyroxine is widely used in donor care, on the basis of observational data suggesting that m...

Original Investigation  December 12, 2023 Metformin Plus Insulin for Preexisting Diabetes or Gestational Diabetes in Early Pregnancy: The MOMPOD Randomized Clinical Trial Kim A. Boggess, Arielle Valint, Jerrie S. Refuerzo, et al JAMA. 2023;330(22):2182-2190. doi:10.1001/jama.2023.22949 Key Points Question  Does metformin added to insulin for the treatment of preexisting type 2 diabetes or diabetes identified early in pregnancy re...

Original Investigation  November 11, 2023 Aspirin and Hemocompatibility Events With a Left Ventricular Assist Device in Advanced Heart Failure: The ARIES-HM3 Randomized Clinical Trial Mandeep R. Mehra, Ivan Netuka, Nir Uriel, MD, et al JAMA. 2023;330(22):2171-2181. doi:10.1001/jama.2023.23204 Key Points Question  Can aspirin be safely avoided as part of an antithrombotic regimen including a vitamin K antagonist with a fully magnetically le...

Original Investigation  Caring for the Critically Ill Patient November 29, 2023 Effect of Noninvasive Airway Management of Comatose Patients With Acute Poisoning: A Randomized Clinical Trial Yonathan Freund, Damien Viglino, Marine Cachanado, et al JAMA. Published online November 29, 2023. doi:10.1001/jama.2023.24391 Key Points Question  In patients with suspected poisoning and Glasgow Coma Scale score less than 9, is a conservative ai...

Research Social media use and health risk behaviours in young people: systematic review and meta-analysis Amrit Kaur Purba, Rachel M Thomson, Paul M Henery, et al BMJ 2023; 383 doi: https://doi.org/10.1136/bmj-2022-073552 (Published 29 November 2023)Cite this as: BMJ 2023;383:e073552 Abstract Objectives To examine the association between social media use and health risk behaviours in adolescents (defined as those 10-19 years). Design Systematic...

Research Air pollution deaths attributable to fossil fuels: observational and modelling study Jos Lelieveld, Andy Haines, Richard Burnett, et al BMJ 2023; 383 doi: https://doi.org/10.1136/bmj-2023-077784 (Published 29 November 2023)Cite this as: BMJ 2023;383:e077784 Abstract Objectives To estimate all cause and cause specific deaths that are attributable to fossil fuel related air pollution and to assess potential health benefits from policies that rep...

ARTICLES|ONLINE FIRST Blood eosinophil-guided oral prednisolone for COPD exacerbations in primary care in the UK (STARR2): a non-inferiority, multicentre, double-blind, placebo-controlled, randomised controlled trial Sanjay Ramakrishnan, Helen Jeffers, Beverly Langford-Wiley, et al. Lancet Respir Med Published: November 01, 2023 DOI:https://doi.org/10.1016/S2213-2600(23)00298-9 Summary Background Systemic glucocorticoids are recommended for use in chr...